The Stand Up To Cancer Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award 2027, administered with AACR as SU2C’s scientific partner, provides up to $225,000 over one to two years for collaborative pancreatic cancer research.
The award supports members of the SU2C scientific community developing innovative partnerships to accelerate new treatments. Priority is given to new SU2C collaborations, with an early-career investigator required among the project’s co-leaders.
Eligibility Criteria
- Applicants must be members of the SU2C scientific community.
- Project co-leaders must come from different institutions.
- At least one co-leader must be an early-career investigator.
- Eligible early-career researchers include junior faculty within seven years of completing training, postdoctoral fellows, clinical research fellows and mentored researchers-in-training.
- At least one applicant must be affiliated with an academic, medical or research institution.
- Each co-leader may submit only one application.
- Industry, nonprofit and government-agency applicants may participate but, as specified in the RFA, are not eligible to receive funds.
Funding Details
- Maximum award: $225,000.
- Duration: One to two years, depending on project scope.
- Funding requires SU2C approval of the final project and budget.
- Annual scientific progress and financial reports are required. research.umgccc.org
Deadline
- Application deadline: December 10, 2026.
- Applications are currently open.
Further Information
Applications require a one-page project description, budget and budget justification.
- Official 2027 request for applications
- Apply through ProposalCentral—search “Stand Up To Cancer.”
- Contact: proposals@su2c.org